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In addition to hypoxia, acidic extracellular pH (pHe) is recognised as one of the microenvironmental characteristics of solid tumours.
A number of studies have examined ways to increase tumour acidity in order to improve tumour-specific targeting of certain drugs
and the effectiveness of hyperthermia. However, previous data have shown that exposure of murine tumour cells to acid conditions
in culture can enhance their metastatic potential when injected subsequently into mice, raising the concern that deliberate tumour
acidification might increase the probability of metastasis. In this study, we examined the effects of in vivo tumour acidification and
hypoxia on the spontaneous metastatic potential of the murine KHT-C fibrosarcoma and B16F1 melanoma cell lines. A tumour-
specific increase in extracellular acidity, demonstrated by measurements with pH electrodes, was achieved by daily intraperitoneal
injections of meta-iodo-benzylguanidine (MIBG) and/or glucose. This method of tumour acidification during tumour growth did not
significantly enhance the spontaneous metastatic potential of the two murine cell lines.
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Tumour acidity is probably caused by excessive production of
lactic and carbonic acids and their insufficient clearance by
abnormal tumour vasculature (Newell et al, 1993; Stubbs et al,
2000; Griffiths et al, 2001). Several studies have examined ways to
further reduce extracellular pH (pHe) in order to improve the
therapeutic index of pH responsive cancer therapies (Wike-Hooley
et al, 1984; Thistlethwaite et al, 1987; Tannock and Rotin, 1989;
Jahde et al, 1992; Kuin et al, 1994). Acidification of the tumour
extracellular space with glucose alone or in combination with
meta-iodo-benzylguanidine (MIBG) provides a means for prefer-
ential intracellular accumulation and enhanced cytotoxicity of
weakly acidic chemotherapeutic drugs, such as chlorambucil (Kuin
et al, 1999; Kozin et al, 2001) and increases tumour cell sensitivity
to hyperthermia (Ohtsubo et al, 2001). Acidification of human
colonic xenografts has also been shown to enhance their sensitivity
to aminolevulinic acid-mediated photodynamic therapy (Piot et al,
2001).
Acidic pH has also been implicated in progression of cultured
human melanoma cells, which were found to have increased
invasiveness through Matrigel following acidic culture conditions
(Martinez-Zaguilan et al, 1996). A similar observation was made
for metastatic B16 mouse melanoma cells where an increase in
invasiveness was accredited to an acidosis-induced increase in
expression of a gelatinase thought to be gelatinase B (matrix
metalloproteinase 9). The relative gelatinase activity was further
shown to be in good agreement with the different metastatic
potentials of three different B16 subclones (Kato et al, 1992). In
separate studies, the ability of murine B16F1 melanoma and KHT
fibrosarcoma cells to form lung metastases after intravenous
injection was shown to increase significantly after exposure to
acidic conditions in culture (Schlappack et al, 1991; Jang and Hill,
1997). In humans, elevated tumour lactate concentrations, which
generally correlate with reduced pHe, have been found to predict
the likelihood of metastatic disease in head and neck and cervical
carcinomas (Parkins et al, 1997; Walenta et al, 2000; Brizel et al,
2001). In addition to upregulated expression of invasion-enhan-
cing proteins such as gelatinases, this increase in metastases may
be related to acidosis-induced elevation of interleukin-8 (IL-8)
and/or vascular endothelial growth factor (VEGF), factors known
for their angiogenic potential (Shi et al, 1999; Xu and Fidler, 2000;
Fukumura et al, 2001; Shi et al, 2001).
High lactate concentrations and low pO2 levels in tumours have
been shown to correlate with increased likelihood of metastatic
disease (Walenta et al, 2000; Brizel et al, 2001; Cairns et al, 2001;
Hill et al, 2001). However, low pO2 levels and acidic pHe are also
known to coexist in solid tumours and thus it has been difficult to
separate the effects of these two factors on metastatic potential in
vivo (Helmlinger et al, 1997; Rofstad, 2000; Hill et al, 2001). To
clarify further the relationship between acidic pH and metastatic
tumour progression, we injected MIBG in combination with
glucose into tumour-bearing mice; this treatment results in
selective tumour acidification by inhibiting mitochondrial respira-
tion at complex I of the electron transport chain and by
stimulation of lactic acid production through anaerobic glycolysis
(Loesberg et al, 1990; Jahde et al, 1992; Kuin et al, 1994, 1999). We
examined the relative contribution of oxygenation and acidity to
the spontaneous metastatic potential of the murine KHT-C
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sfibrosarcoma and B16F1 melanoma cells by treating tumour-
bearing mice daily with glucoseþMIBG alone or in combination
with a strategy to simulate acute hypoxia (Cairns et al, 2001).
MATERIALS AND METHODS
Animals and tumours
The experiments were carried out with two previously described
murine cell lines: KHT-C fibrosarcoma and B16F1 melanoma,
which were maintained using an alternating in vivo–in vitro
growth protocol (Bristow et al, 1990). Cells were propagated in
vitro in a-MEM media supplemented with 10% foetal calf serum
and antibiotics. For in vivo experiments 2–5 10
5 cells were
injected intramuscularly into the gastrocnemius muscle of the left
hind leg of 8–12-week old C3H-HeJ male (KHT-C) and C57Bl/CRL
female (B16F1) mice to produce tumours as described previously
(Cairns et al, 2001). Tumour growth was monitored daily by leg
diameter measurements, which were converted into tumour weight
by a previously made standard curve. Animals were maintained in
the Animal Resource Centre of the Ontario Cancer Institute/
Princess Margaret Hospital and all procedures on the animals had
the ethical approval of the Animal Care Committee in compliance
with the guidelines of the Canadian Council on Animal Care. These
guidelines meet the standards required by the UKCCCR (Work-
man et al, 1998).
pHe and pO2 measurements
Prior to and at 1 and 3h following glucose7MIBG injections, mice
with tumours weighing B0.4–0.5g (B9.0–10.0mm) were re-
strained in a jig. Following a two-point calibration (Fisher
Scientific standardising buffers 4.01 and 7.00; slope min 80%), a
21G needle electrode (type MI-418, Microelectrodes Inc., Bedford,
NH, USA connected to ORION pH meter, model 230A, Boston MA,
USA) was inserted into the tumour through a premade 21G needle
puncture in the skin and withdrawn in a stepwise manner to
record pH values at different depths. A reference electrode (type
MI-402, Microelectrodes Inc., Bedford, NH, USA) was placed
subcutaneously in the same leg. Any drift caused by protein
contamination of the needle probe was assessed by placing both of
the probes back into pH 7.00 standardising buffer after the
measurement of each tumour and by recording the difference that
had occurred during the measurement. All of the pH values
presented are corrected for their individual drifts, which on
average was þ0.03 pH units following approximately 10min
measurement interval. This drift increased significantly with
increasing measurement time, thus preventing accurate measure-
ments of long-term pHe changes in the tumours. The probes were
rinsed with distilled water and recalibrated with pH 7.00 buffer
following measurements in every mouse.
Measurements of tissue oxygenation were made using the
fibreoptic-based OxyLite system (Oxford Optronix, Oxford, UK) as
described previously (Cairns et al, 2001) in a restraint set-up
identical to that used for pHe measurements. The probe was placed
initially in a region of the tumour with a pO2 value around 5–
10mmHg and then left in place for a number of hours. Data
recording was initiated within 30min of injection with gluco-
seþMIBG. To obviate the possibility of metastatic contribution by
dislodged tumour cells, no needle electrode or pO2 measurements
were made in the tumours of mice used to generate the
spontaneous metastasis data. All measurements were carried out
without general anaesthetics.
Tumour treatment protocol for metastasis experiments
Treatment to induce tumour acidification was started when the
diameter of the tumour-bearing leg reached 7.5mm (0.23g; about
5–7 days after tumour inoculation). Earlier initiation of treatment
resulted in a significant inhibition of tumour growth. Mice in the
treatment group were injected with 30mgkg
 1 MIBG (a gift from
Dr Dewhirst, Durham, NC, USA) in phosphate-buffered saline
(PBS) intraperitoneally (i.p.), immediately followed by 3gkg
 1
glucose (i.p.) in distilled water. Owing to different tolerance levels,
the drug was administered in different schedules to the two
different mouse strains. The C3H-HeJ males with KHT-C tumours
received glucoseþMIBG on every other day and on the
intervening day only glucose was administered at a dose of
3gkg
 1. The C57Bl/CRL females with B16F1 tumours received
glucoseþMIBG on two consecutive days followed by a day on
which only glucose was administered at a dose of 3gkg
 1. Control
animals received an equal number of daily PBS injections. This
treatment schedule was repeated until a predetermined tumour
weight was reached. In two experiments, a separate group of KHT-
C tumour-bearing animals were treated with glucose alone,
receiving single daily doses of glucose at 3gkg
 1.
In experiments identified as ‘combination treatments’, the above
injections were given together with daily treatments to simulate
acute hypoxia. This consisted of 12 alternating breathing cycles of
10min 7% O2, balance N2 and 10min air for the treatment animals
and of 240min air breathing for the control animals. In the
treatment animals, this resulted in pO2 fluctuations between
approximately 40 and 10mmHg in normal muscle and between
o10 and near 0mmHg in the tumour. The acute hypoxia
treatment was started on the day following tumour cell inoculation
as was done previously (Cairns et al, 2001). During the days when
animals received the combination treatment, control mice were
injected first (with PBS) followed by the treatment group (with
glucose7MIBG). Immediately following the i.p. injections, animals
were exposed to either the control or acute treatment conditions of
the gassing programme.
Mice with KHT-C tumours were killed when the tumour weight
reached 0.4570.05g (9.070.5mm; 4–5 days of tumour-acidifying
treatment). Owing to their higher drug tolerance levels and lower
metastatic efficiency, mice with B16F1 tumours were killed when
the tumour weight reached 1.770.17g (15.070.5mm) or a
maximum of 6 days of tumour-acidifying treatment, whichever
end point was reached first. The lungs were then removed for
histological assessment of micrometastases where four individual
5mm sections, separated by at least 200mm, were obtained from
each lung and examined as described previously (Cairns et al,
2001). Experiments examining metastasis with acute hypoxia alone
or in combination with glucoseþMIBG injections in the KHT-C
model were repeated four times with 5–12 mice per repeat group
with total number in each group ranging from 28 to 33. Glucose
with or without acute hypoxia experiments in the KHT-C model
was repeated twice with 7–13 animals per repeat group and 17–23
animals in total. A single experiment with 13–15 animals per
group was carried out to examine metastasis in the B1F1 model.
Tumour treatment protocol for nonmetastasis experiments
Additional mice were used to assess the effects of previously
described tumour microenvironmental manipulations on tumour
pHe. Generally, pretreatment measurements were obtained 1 day
prior to or on the day of treatment. For measurements of tumour
pHe following acute hypoxia, one mouse was removed from the
treatment chamber and tumour pHe was measured during the first
reoxygenation cycle of the hypoxia treatment. The next mouse was
measured during the second reoxygenation cycle and this was
repeated until all of the animals were measured during B160min
of acute hypoxia. When this treatment was combined with tumour-
acidifying injections, mice were injected with one dose of
glucoseþMIBG prior to treatment with acute hypoxia and were
measured as described for acute hypoxia treatment alone. Mice
used to examine the kinetics of pHe reduction received multiple
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sinjections in a schedule similar to that used with animals in the
metastasis experiment.
Statistical analysis
The Student’s t-test with Bonferroni correction was applied to the
normally distributed data sets (the pHe values). The Kruskal–
Wallis ranking test was used on the nonparametric data sets with
three or more treatment groups with the limit of statistical
significance set at Po0.05. A power analysis of the metastasis data
was performed to determine its ability to detect a difference. As the
data is not normally distributed, it was log-normalized and the
pooled variance was calculated. Methods described by Bausell and
Li (2002) were used to determine the minimum difference that
could have been detected with a P-value of 0.05 and a power of
80%.
RESULTS
Effects of glucose7MIBG and acute hypoxia on tumour
pHe
Pooled pHe values measured before and approximately 1h after
treatment demonstrate the degree of acidification achieved with
various treatments in the KHT-C (Figure 1A) and in the B16F1
(Figure 1B) tumours. Maximal acidification of the KHT-C tumours
(mean change in pHe: 0.24U; P¼1.0 10
 8) was observed
following glucoseþMIBG injections. This treatment also signifi-
cantly acidified the B16F1 tumours (mean change in pHe: 0.25U;
P¼6.6 10
 5), as did acute hypoxia (mean change in pHe: 0.13U;
P¼0.027), but the B16 F1 tumours were found to become most
acidic when these two treatment modalities were combined (mean
change in pHe: 0.35U; P¼8.2 10
 7). In B16F1 tumours, the acute
hypoxiaþglucoseþMIBG-treated group is significantly different
from the glucoseþMIBG-treated group (P¼3.35 10
 9). In the
KHT-C tumours, addition of acute hypoxia to glucoseþMIBG
injections increased mean tumour pHe as compared to the
injections alone (mean difference: 0.08U). Acute hypoxia alone
also increased KHT-C tumour pHe (mean change in pHe: 0.10U;
P¼0.016), but the biological significance of this increase remains
undetermined. In accordance with previous reports (Jahde et al,
1992; Zhou et al, 2000), glucoseþMIBG injections had no
significant effect on normal tissue (untreated muscle pHe:
7.0070.074 vs 7.0770.046 s.e.m. 1h postinjections).
Examples of individual tumour responses during the first 4 days
of tumour-acidification treatment with glucoseþMIBG are shown
in Figure 2. In most tumours, measurements of mean pHe values in
individual mice showed maximal acidification within 1h after
injections and return of these values near to their pretreatment
values within 3h of injection. The mean degree of KHT-C tumour
acidification following glucoseþMIBG injections ranged from 0.06
to 0.28 pH units. The mean degree and duration of tumour
acidification achieved with less toxic glucose on days 8 and 10 for
KHT-C (Figure 2A) appears equivalent to those achieved with
glucoseþMIBG on days 7 and 9, which would suggest the use of
glucose alone for tumour acidification to limit the observed
toxicity. However, when used without intervening MIBG injec-
tions, a dose of up to 6gkg
 1 glucose resulted in only a 0.1U
reduction in tumour pHe, which returned back to normal within
1h (data not shown). This moderate tumour sensitivity to glucose
suggests that the greater mean degree of tumour acidification (0.26
pH units) achieved with glucose alone in Figure 2A, is likely due to
inflated pretreatment measurements, which on the days following
glucoseþMIBG injections, are 0.19 pH units above the mean
untreated pHe levels of 7.12. This apparent overcompensation of
tumour pHe in response to glucoseþMIBG within 24h of
injections was taken into account in generating data for panel B,
Figure 2, by making all pretreatment measurements prior to any
injections, on day 7. In B16F1 tumours, glucoseþMIBG injections
resulted in reductions ranging from 0.10 to 0.38 pH units. Thus,
although the mean pHe in every tumour decreased after each daily
treatment, heterogeneity in the responses of individual mice was
evident.
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Figure 1 Histograms of pooled pHe values before and after treatment in
KHT-C and B16F1 tumours. (A) KHT-C: Control: pretreatment measure-
ments from animals used for post-treatment measurements, obtained 1 day
prior to or on the day of treatment. Mean pHe¼7.1370.017; N¼25;
n¼179. GlucoseþMIBG: Animals treated with 3gkg
 1
glucoseþ30mgkg
 1 MIBG were measured 1h postinjections. Mean
pHe¼6.8970.030; N¼12; n¼99. Acute hypoxia: mice were measured
during reoxygenation cycles of 160min of acute hypoxia treatment. Mean
pHe¼7.23þ0.045, N¼8; n¼51. Acute hypoxiaþglucoseþMIBG:
animals were injected with one dose of glucoseþMIBG prior to acute
hypoxia and were measured as described for acute hypoxia alone. Mean
pHe¼6.9770.031; N¼5; n¼32. (B) B16 F1: animals were measured as
described for the KHT-C tumours, unless specified otherwise. Control: all
pretreatment measurements were made on the day of the first treatment.
Mean pHe¼7.1470.022; N¼19; n¼152. GlucoseþMIBG: measure-
ments were carried out following 1–3 rounds of injections on days 7–9.
Mean pHe¼6.8970.064; N¼6; n¼48. Acute hypoxia: mean
pHe¼7.0170.063; N¼4; n¼33. Acute hypoxiaþglucoseþMIBG: mean
pHe¼6.7970.042; N¼4; n¼36. (mean71 s.e.m.; N¼the number of
animals used; n¼pooled number of pH readings obtained).
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sEffects of tumour acidification on pO2
MIBG is a known inhibitor of mitochondrial respiration (Smets
et al, 1988; Biaglow et al, 1998; Loesberg et al, 1990) and a
hyperglycaemia-induced shift to glycolysis has been shown to alter
cellular oxygen consumption (Nadal-Desbarats et al, 2002).
Therefore, we examined whether the glucoseþMIBG treatment
could result in an increase in tumour pO2 as reported by others
(Burd et al, 2001, 2003). The pO2 levels were measured in six KHT-
C and two B16F1 tumours with two probes/tumour in all but one
case. Recording of data was initiated within 30min of gluco-
seþMIBG injections in four KHT-C tumours (Figure 3A) or prior
to injections in two KHT-C (Figure 3B) and two B16F1 tumours
(Figure 3C). As reported recently by Brurberg et al (2003), it can
take up to 15min for measurements with an OxyLite probe to
stabilize, hence the early measurements shown in this figure
should be viewed with caution. No consistent changes in tumour
pO2 levels in response to tumour acidification were observed.
Effects of tumour acidification and acute hypoxia on
metastases
Results of microscopic lung metastasis data from four repeat
experiments are shown individually in Table 1 and the combined
data is shown in Figure 4. Tumour acidification with gluco-
seþMIBG did not significantly increase the spontaneous meta-
static potential of either cell line (KHT-C pooled median:
control¼17, treatment¼20; B16F1 median: control¼1,
treatment¼2). Although the degree of KHT-C tumour acidifica-
tion achieved with daily glucose injections was less than that
achieved glucoseþMIBG, we also examined the effects of daily
3gkg
 1 glucose injections on metastatic efficiency (mean resultant
pHe¼7.0670.017; N¼5; n¼34). The number of micrometastases
in this group did not differ from the groups treated with PBS or
glucoseþMIBG (KHT-C pooled median: control¼17,
treatment¼20). Treatment of the KHT-C tumours with acute
hypoxia alone led to a nonsignificant increase in microscopic
metastases in three of four experimental repeats (Table 1). None of
the treatments had an effect on the metastatic potential of the
B16F1 tumours.
DISCUSSION
Current evidence suggests that the tumour microenvironmental
characteristic, acidic pHe, can be exploited and enhanced to
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Figure 2 Kinetics of pHe reduction following tumour-acidification
treatments on four consecutive days in KHT-C and B16 F1 tumours. The
distribution of pHe was measured daily in total of seven different tumour-
bearing animals. One animal on day 8 in panel A was omitted due to a
missed time point and another animal on day 10 in panel B died. The three
connected circles for each animal represent pre-, 1h post- and 3h
postinjection time points. Maximal reduction in mean pHe of both tumour
models was generally observed at the first time point, 1h post-treatment
and pHe returned near the initial value by 3h post-treatment. (A) KHT-C
(N¼7): pretreatment measurements were made on each day of the
treatment during days 7–10. Injections consisted of 3gkg
 1
glucoseþ30mgkg
 1 MIBG on days 7 and 9 and of 3gkg
 1 glucose on
days 8 and 10. (B) B16F1 (N¼7): all pretreatment measurements were
obtained on day 7. The animals were treated with 3gkg
 1
glucoseþ30mgkg
 1 MIBG on days 7–9 and with 3gkg
 1 glucose alone
on day 10.
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Figure 3 Oxygen tension measurements in KHT-C and B16F1 tumours
treated with 30mgkg
 1 MIBGþ3gkg
 1 glucose. Most tumours (seven
out of eight) were concurrently monitored with two OxyLite probes. No
consistent changes in pO2 levels in response to the injections were
observed. (A) KHT-C tumours (N¼4); measurements were started within
30min of injections and continued up to 3h after treatment. (B) KHT-C
tumours (N¼2); measurements were started prior to injections, marked
by K and , and continued for 1–2h after treatment. (C) B16F1 tumours
(N¼2); measurements were started prior to injections, marked by K and
, and continued up to 2h after treatment.
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simprove the efficacy of hyperthermia, certain forms of chemother-
apy and photodynamic therapy (Wike-Hooley et al, 1984;
Tannock and Rotin, 1989; Jahde et al, 1992; Kuin et al, 1994,
1999; Kozin et al, 2001; Ohtsubo et al, 2001; Piot et al, 2001).
However, acidic pH and lactate have also been associated
with enhanced metastatic tumour progression both in experi-
mental models (Schlappack et al, 1991; Jang and Hill, 1997) and
clinically (Parkins et al, 1997; Walenta et al, 2000; Brizel et al,
2001). We wanted to determine whether the glucoseþMIBG-based
tumour-acidifying treatment, used to improve efficacy of
cancer therapies, would affect the spontaneous metastatic potential
of two murine tumour cell lines, KHT-C and B16F1, previously
shown to increase their experimental metastatic potential
following acidic culture conditions (Schlappack et al, 1991; Jang
and Hill, 1997).
Significant acidification of the two tumour types following
glucoseþMIBG injections was achieved. The mean reduction was
0.24 pH units for KHT-C and 0.25 pH units for B16F1 tumours.
Although these reductions are smaller and subsequently return
back to original levels faster than has been reported previously
following glucoseþMIBG treatment in mouse models (Jahde et al,
1992; Kuin et al, 1994), they are very similar to those achieved with
glucose treatment alone in cancer patients without local anaes-
thesia where the mean reduction ranged from 0.16 to 0.19 pH units
(Leeper et al, 1998). The difference between studies conducted in
mice is likely a combination of the use of different mouse and
tumour cell lines, different dose and route of glucose administra-
tion and a lower dose of MIBG, which was limited by toxicity. In
the B16F1 tumours, which were grown in female mice, this may
also be due partly to the sex of the animals since Kuin et al (1994)
have previously reported that the degree of RIF-1 tumour
acidification was less in female mice than in identically treated
male mice.
Despite previously demonstrated cyclical reduction in tumour
pO2 during acute hypoxia and evidence for enhanced glycolysis
rates following hypoxic culture conditions (Skoyum et al, 1997;
Cairns et al, 2001), acute hypoxia resulted in a small reduction in
pHe only in the B16F1 model. The mean change from the untreated
control values was þ0.10 pH units for the KHT-C (range: from
 0.15 to þ0.41 pH units) and  0.13 pH units for the B16F1
tumours (range: from  0.26 to þ0.14 pH units; Figure 1). The
dissimilarity of these two different tumour cell lines in their
responses to acute hypoxia may represent an extension of previous
reports outlined in the thorough review by Wike-Hooley et al
(1984) where the mean pH values of untreated mouse tumours
were reported to vary from a mean of 6.74 (range 6.65–6.93) in a
hepatoma to a mean of 7.1 (range 6.8–7.4) in a mammary
adenocarcinoma.
It was also anticipated that hypoxia-induced oxygen deficiency
together with the mitochondrial respiration inhibitor, MIBG,
might further shift energy production from aerobic to anaerobic
glycolysis with subsequent increase in acid production and further
decrease in tumour pHe. Despite the variability in individual
mouse responses to acute hypoxia treatment alone, this appears to
hold true for the B16F1 tumours as the reduction of 0.35U in mean
tumour pHe following the combination treatment is close to the
added mean values of 0.13 and 0.25 pH units from acute hypoxia
and glucoseþMIBG treatments, respectively. The degree of
acidification observed with the combination treatment in the
KHT-C model (mean change in pHe: 0.16U) was less than that seen
with glucoseþMIBG alone (mean change in pHe: 0.24U), which is
again consistent with the increase in pHe induced by acute hypoxia
(0.10 pH units). However, the reason for the increase in pHe due to
Table 1 Median number of microscopic lung metastases in individual
experimental repeats
Air Hypoxia
PBS Glu+MIBG PBS Glu+MIBG
Repeat 1 5 (6) 24 (6) 17 (5) 14 (6)
Repeat 2 6 (5) 3 (5) 13 (6) 35 (6)
Repeat 3 27 (10) 20 (10) 35 (9) 14 (9)
Repeat 4 26 (12) 29 (12) 18 (8) 35 (8)
Median (pasted) 17 20 18 24
First/third quartiles 8/43 17/50 6/38 11/48
Hypoxia gassing alone showed an increased number of lung metastases in three of
four experiments, although no individual repeat showed statistical significance.
Tumour acidification injections with glucose+MIBG resulted in a nonsignificant
increase in the number of metastases in two of four experimental repeats both under
air control and hypoxic gassing conditions. Number of experimental animals per
group is indicated in parenthesis.
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Figure 4 Microscopic lung metastases detected in KHT-C or B16F1
tumour-bearing animals treated with glucoseþMIBG (&), glucose (})o r
control injections (PBS, n) in combination with acute hypoxia or control air
gassing conditions, indicated by solid and open symbols, respectively. (A)
KHT-C: pooled medians from 2–4 repeat experiments (R): Air, PBS¼17
(4R, N¼33); Air, glucoseþMIBG¼20 (4R, N¼33); Air, glucose¼20
(2R, N¼23); Hypoxia, PBS¼18 (4R, N¼28); Hypoxia,
glucoseþMIBG¼24 (4R, N¼29); Hypoxia, glucose¼25 (2R, N¼17).
(B) B16F1: medians from one set of experiments: Air, PBS¼1( N¼15);
Air, glucoseþMIBG¼2( N¼15), Hypoxia, PBS¼2( N¼14); Hypoxia,
glucoseþMIBG¼1( N¼13).
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sexposure to acute hypoxia remains unclear. Tumour cell
metabolism has been found to be limited primarily by substrate
availability, such as glucose for anaerobic glycolysis, rather than
the metabolic demands by tumour cells (Kallinowski et al,
1988; Helmlinger et al, 2002). Therefore, it seems possible that
the combination treatment of the KHT-C model caused
such a severe depletion of energy stores that little additional
acidification from the pre-existing levels was attainable. This
alternative is supported by studies by Rotin et al (1986) in which
culturing cells under acidic and hypoxic conditions led to a
decrease in cellular ATP levels and in the rates of glucose
consumption and lactate production. These data are also
consistent with the observation where the combination treatment
slightly inhibited (o1 day) the development of KHT-C tumours
although it had no effect on the growth rate of B16F1 tumours
(data not shown).
Previous studies have reported that MIBG can reduce oxygen
consumption by tumour cells (Smets et al, 1988; Loesberg et al,
1990; Biaglow et al, 1998;), therefore we examined whether our
tumour-acidifying protocol had secondary effects on tumour
oxygenation. The KHT-C fibrosarcoma used in this study has
previously been shown to be hypoxic with HP5 values (tumour pO2
values o5mmHg) ranging from 25–100% in individual tumours
(median 68%); similar values have been reported in clinical soft
tissue sarcomas with HP5 values ranging from 0–76% (Brizel et al,
1994; Nordsmark et al, 1996; De Jaeger et al, 2001). We observed
no consistent change in tumour pO2 levels following gluco-
seþMIBG injections in either tumour model (Figure 3). If the
increase in pO2 levels were immediate, it is possible that the
increase would have been missed in our initial study (panel A), as
it took approximately 30min to start pO2 recording after the
injections. However, a group of pO2 measurements (panels B and
C) were made in a set-up that allowed glucoseþMIBG injections
to be administered without removing the OxyLite probes and again
no consistent changes in pO2 levels were observed. A possible
explanation for the lack of a detectable change is offered by
Kallinowski et al (1989), who postulated that a decrease in oxygen
consumption by tumour cells may be concealed by an up to 70-fold
elevation in oxygen consumption by immune cells. Approximately
40% of cells from dissociated KHT-C tumours have been reported
to be immune cells, primarily macrophages (Siemann et al, 1981).
Alternatively, this observation may be due to the absence of
anaesthetics in the current study, use of which has been reported
to influence tissue pHe and pO2 (Buelke-Sam et al, 1978; Kerger
et al, 1997). These data suggest that the glucoseþMIBG-mediated
increase in tumour oxygenation and subsequent increase in
radiosensitivity reported by Burd et al (2001, 2003) may be
applicable only to certain tumours.
The absence of a change in the spontaneous metastatic potential
in response to in vivo tumour acidification (Figure 4) was
unexpected and may be due to inherent differences between the
in vitro and in vivo systems. With the KHT-C tumours, the degree
of acidification achieved with glucoseþMIBG was significant, but
was applied only during the second half of total tumour
development time for a total of approximately 4 days. While this
is consistent with any likely clinical application of such a
treatment, it is a considerably shorter time and reduced treatment
frequency than that used with animals treated with acute hypoxia.
MIBG also had significant growth inhibitory effects on the KHT-C
tumours if the injections were started before a palpable tumour
was present. Although cell lines are generally highly capable of
maintaining alkaline intracellular pH (pHi) even when the pHe is
as low as 6.2 (Lee and Tannock, 1998; Kozin et al, 2001), there is
evidence that suggests that MIBG acidifies tumour cell pHi via an
unknown mechanism (Biaglow et al, 1998; Kuin et al, 1999; Zhou
et al, 2000). It is therefore possible that MIBG-induced cytotoxic
effects may have counteracted the potential metastasis promoting
effects of tumour acidification. In an attempt to examine less toxic
methods to achieve tumour acidification and to increase the
number of days when the treatment was implementable, we tested
carbogen (95% O2/5% CO2) breathing, which has been reported to
result in significant tumour-specific acidification without growth
inhibition (Stubbs et al, 1998). However, we saw no change in
mean pHe of the KHT-C tumours following 2h of carbogen
breathing (data not shown). To rule out the potential of MIBG-
induced increases in tumour oxygenation and subsequent
possibility of inhibition of metastasis formation, the tumour-
acidifying treatment was also combined with acute hypoxia. The
median number of lung metastases in this combination treatment
group did not differ from the medians of the groups receiving
either treatment alone. We believe that this addition of hypoxia to
the tumour-acidifying regime should have been able to compen-
sate any possible increases in tumour oxygenation and thus
prevent masking of a positive effect of acidification on metastasis
formation. We also examined the power of our data set to detect a
difference. Based on this analysis, the data for MIBGþglucose has
80% power to detect a difference greater than 2.7-fold in metastasis
formation. We conclude that if the pHe changes induced by the
treatment do cause an effect, it is unlikely to be larger than a 2.7-
fold difference.
Owing to higher tolerance to MIBG, the B16F1 tumour model
received tumour-acidifying injections longer and more frequently
than the KHT-C model. The maximal degree of acidification was
also higher in the B16F1 model (0.35 pH units vs 0.24 pH units for
KHT-C). Despite this, no increase in metastases was observed
contrary to our previous in vitro studies (Schlappack et al, 1991;
Jang and Hill, 1997). The maximal mean reduction achieved in vivo
remained significantly lower than the reduction of 0.7 pH units
achieved in vitro (control pH 7.2, treatment pH 6.5). The acidic
conditions were also maintained much longer in vitro (48h,
followed by a 24–48h recovery period) than in vivo (o3h). Thus,
the acidic exposure in vitro was much more severe than could be
achieved in vivo, which may explain the differences in the results
obtained. This outcome may also be partially due to the low
spontaneous metastatic efficiency of the B16F1 cell line. It is well
known that growth site of the primary tumour can have a
significant impact on the (metastatic) outcome of any given
experiments and the predominant view supports an orthotopic
rather than nonorthotopic site for maximal spontaneous meta-
static effect (Manzotti et al, 1993; Blouw et al, 2003). It is possible
that in our case, intradermally injected tumours might have given
more metastases, however, such tumours tend to ulcerate at small
sizes and we felt that they would be unsuitable for a study
involving multiple needle insertions (personal observation, R
Kuba).
In light of our previous data, which showed a significant
increase in experimental metastatic potential by KHT-C and
B16F1 cells following acidic culture conditions, the absence of an
increase in spontaneous metastases underscores the complexity
associated with the effect of the tumour microenvironment
on malignant disease progression. Together with studies
using noninvasive, in vivo pH quantifying imaging techniques,
such as those described Gillies et al (2002), the current study,
attaining a degree of tumour-acidification matching that achieved
in the clinics, should provide valuable information about the
potential risk–benefit ratio of tumour-acidification treatment in
humans.
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